Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC.
J Oncol Pharm Pract. 2024 Apr 13:10781552241241004. doi: 10.1177/10781552241241004. Online ahead of print.
J Oncol Pharm Pract. 2024.
PMID: 38613329
Tailoring adjuvant chemotherapy by circulating tumor DNA (ctDNA) in older patients with stage II-III colon cancer.
Akagündüz B, Guven DC, Ozer M, Okten IN, Atag E, Unek İT, Tatli AM, Karaoglu A.
Akagündüz B, et al. Among authors: okten in.
J Geriatr Oncol. 2023 Mar;14(2):101367. doi: 10.1016/j.jgo.2022.08.016. Epub 2022 Aug 26.
J Geriatr Oncol. 2023.
PMID: 36038467
No abstract available.
Item in Clipboard
Psychological impacts of COVID-19 pandemic in cancer patients on active treatment.
Koca S, Koca E, Okten IN, Orengül FF, Oztürk A, Ozçelik M, Oyman A, Çil I, Gümüş M.
Koca S, et al. Among authors: okten in.
Heliyon. 2022 Aug;8(8):e10142. doi: 10.1016/j.heliyon.2022.e10142. Epub 2022 Aug 18.
Heliyon. 2022.
PMID: 35996550
Free PMC article.
Item in Clipboard
Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study.
Cil I, Kucukarda A, Atcı MM, Secmeler S, Paksoy N, Ferhatoglu F, Ak N, Ayhan M, Tataroglu Ozyukseler D, Onder AH, Avci O, Oyman A, Okten IN, Gulturk I, Akagunduz B, Basoglu T, Cakir E, Hacibekiroglu I, Ozcelik M, Aydiner A.
Cil I, et al. Among authors: okten in.
Tumori. 2022 Feb;108(1):19-25. doi: 10.1177/03008916211037739. Epub 2021 Aug 7.
Tumori. 2022.
PMID: 34365852
Item in Clipboard
Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment?
Alan O, Akin Telli T, Aktas B, Koca S, Ökten IN, Hasanov R, Basoglu T, Arikan R, Demircan NC, Ercelep O, Kaya S, Ugurlu MU, Kaya H, Akgul Babacan N, Dane F, Yumuk PF.
Alan O, et al. Among authors: okten in.
World J Surg Oncol. 2020 Sep 9;18(1):242. doi: 10.1186/s12957-020-02019-y.
World J Surg Oncol. 2020.
PMID: 32907593
Free PMC article.
Item in Clipboard
Preclinical discovery and clinical development of encorafenib for the treatment of melanoma.
Okten IN, Ismail S, Withycombe BM, Eroglu Z.
Okten IN, et al.
Expert Opin Drug Discov. 2020 Dec;15(12):1373-1380. doi: 10.1080/17460441.2020.1795124. Epub 2020 Jul 28.
Expert Opin Drug Discov. 2020.
PMID: 32720533
Item in Clipboard
VEGF-VEGFR pathway seems to be the best target in hepatic epithelioid hemangioendothelioma: A case series with review of the literature.
Telli TA, Okten IN, Tuylu TB, Demircan NC, Arikan R, Alan O, Ercelep O, Ones T, Yildirim AT, Dane F, Yumuk PF.
Telli TA, et al. Among authors: okten in.
Curr Probl Cancer. 2020 Oct;44(5):100568. doi: 10.1016/j.currproblcancer.2020.100568. Epub 2020 Mar 14.
Curr Probl Cancer. 2020.
PMID: 32201052
Review.
Item in Clipboard
Cite
Cite